PURE BIOSCIENCE, INC. (PURE) › Cash & EquivalentsPURE BIOSCIENCE, INC. (PURE) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2010: $2.19M2011: $1.79M2012: $877.0K2013: $32.0K2014: $86.0K2015: $1.32M2016: $5.19M2017: $1.64M2018: $851.0K2019: $398.0K2020: $3.84M2021: $2.39M2022: $3.39M2023: $1.09M2024: $349.0K2025: $334.0K$334.0K2010Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$334.0K-4.3%2024$349.0K-68.1%2023$1.09M-67.7%2022$3.39M+41.9%2021$2.39M-37.7%2020$3.84M+864.6%2019$398.0K-53.2%2018$851.0K-48.1%2017$1.64M-68.4%2016$5.19M+293.2%2015$1.32M+1436.0%2014$86.0K+168.8%2013$32.0K-96.4%2012$877.0K-51.1%2011$1.79M-18.2%2010$2.19M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share